Company page

Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc. is a public company traded under the ticker RAPP in the American market. The company has a market capitalization of approximately $1.89 billion. Rapport Therapeutics focuses on developing innovative therapies, contributing to advancements in healthcare.

profileRAPPAI content: aiUpdated May 29, 2026/company/rapport-therapeutics-inc-common-stock
Rapport Therapeutics, Inc. logo
Ticker
RAPP
Market cap
$1.89B
Sector
Health Technology
Industry
Biotechnology